STABLE EXTENDED RELEASE ORAL DOSAGE COMPOSITION
PROBLEM TO BE SOLVED: To provide a stable extended release oral dosage composition, wherein a release rate profile of pseudoephedrine constituent, while maintaining the delivery of an effective once daily dosage of desloratadine, has achieved such a long term target as 12 hours, or optimally over 16...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To provide a stable extended release oral dosage composition, wherein a release rate profile of pseudoephedrine constituent, while maintaining the delivery of an effective once daily dosage of desloratadine, has achieved such a long term target as 12 hours, or optimally over 16 hours.SOLUTION: This is a film-coated extended release solid oral dosage composition having (a) a core that contains an effective amount of pseudoephedrine or a pharmaceutically acceotable amount of salt thereof, and (b) a film coating constituent that uniformly covers the core and contains an effective amount of desloratadine. |
---|